Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Proprietary compound preparation BNF 0905048
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Solgar Chelated Copper 2.5mg tablets
090504800BBEHA0
|
Proprietary compound preparation BNF 0905048 | Other mineral formulation preparations | Nutrition and Blood | 61 |
|
Vega Calcium Magnesium Zinc plus Boron capsules
090504800BBFYA0
|
Proprietary compound preparation BNF 0905048 | Other mineral formulation preparations | Nutrition and Blood | 3 |
|
Minalka tablets
090504800BBBLA0
|
Proprietary compound preparation BNF 0905048 | Other mineral formulation preparations | Nutrition and Blood | No data available |
|
Solgar Boron 3mg capsules
090504800BBENA0
|
Proprietary compound preparation BNF 0905048 | Other mineral formulation preparations | Nutrition and Blood | No data available |
|
Tri-Salts powder
090504800BBHHA0
|
Proprietary compound preparation BNF 0905048 | Other mineral formulation preparations | Nutrition and Blood | No data available |
|
ZMM Multiminerals capsules
090504800BBHIA0
|
Proprietary compound preparation BNF 0905048 | Other mineral formulation preparations | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.